[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

2018 France Sexually-Transmitted Diseases (STD) Testing Market: Supplier Shares and Sales Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities

June 2018 | 280 pages | ID: F0DD0DAFA39EN
Venture Planning Group

US$ 1,950.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
About This Report

This new 280-page report from VPGMarketResearch.com presents detailed analysis of the French STD market, including sales forecasts and supplier shares for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear, HPV), and Syphilis.

The report provides test volume and sales projections for Hospitals and Commercial/Private Labs.In addition to market share and sales forecasts, the report:
  • Examines market applications of Molecular Diagnostics, Monoclonal Antibodies, Immunoassays, IT and other emerging technologies;
  • Reviews features and operating characteristics of major analyzers used for STD testing;
  • Profiles key suppliers and potential market entrants developing innovative technologies and products;
  • Analylzes emerging opportunities, alternative market penetration strategies, market entry barriers/risks, and strategic planning issues.
Methodology

The report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products.In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product and financial literature, as well as VPGMarketResearch's proprietary data files was conducted.

Contains 280 pages and 17 tables.
I. INTRODUCTION

II. WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW

A. Major 1nfectious Disease Tests
  1. CHANCRO1D
    a. Background
    b. Diagnostic Tests
    c. 5accines and Drugs
  2. CHLAMYD1A
    a. Background
    b. Diagnostic Tests
    c. 5accines and Drugs
  3. GONORRHEA
    a. Background
    b. Diagnostic Tests
    c. 5accines and Drugs
  4. HERPES S1MPLE10 6RUS
    a. Background
    b. Diagnostic Tests
    c. 5accines and Drugs

HUMAN HERPES 5IRUS-6 (HH5-6)

    a. Background
    b. Diagnostic Tests
    c. 5accines and Drugs
  5. PAP1LLOMA6RUS (HP5)
    a. Background
    b. Diagnostic Tests
    c. 5accines and Drugs
  6. SYPH1L1S
    a. Background
    b. Diagnostic Tests
    c. 5accines and Drugs
B. 1nstrumentation Review of Leading Analyzers Marketed by Abbott, Beckman Coulter/Danaher, BioMerieux, Ortho-Clinical Diagnostics, Roche, Siemens, Tosoh, Wallac and Other Suppliers
C. Emerging Diagnostic Technologies
  1. MOLECULAR D1AGNOST1CS
  2. MONOCLONAL ANT1BOD1ES
  3. 1MMUNOASSAYS
  4. D1FFERENT1AL L1GHT SCATTER1NG
  5. 1NFORMAT1ON TECHNOLOGY
  6. ART1F1C1AL 1NTELL1GENCE
  7. L1POSOMES
  8. FLOW CYTOMETRY
  9. CHROMATOGRAPHY
  10. D1AGNOST1C 1MAG1NG
  11. GEL M1CRODROPLETS
  12. OTHER

III. FRANCE: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES

ALTERNATIVE MARKET PENETRATION STRATEGIES

A. 1nternal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
  1. MARKET1NG APPROACHES
  2. PRODUCT COMPLE11TY
  3. CUSTOMER PREFERENCE
  4. ESTABL1SHED SUPPL1ERS
  5. EMERG1NG SUPPL1ERS
  6. MAJOR TYPES OF D1STR1BUTORS
  7. MARKET SEGMENTAT1ON

POTENTIAL MARKET ENTRY BARRIERS AND RISKS

A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

COMPETITIVE ASSESSMENTS

Abbott
Affymetrix
Beckman Coulter/Danaher
Becton Dickinson
bioMerieux
Bio-Rad
Cepheid
Diamedix/Erba
DiaSorin
Eiken Chemical
Elitech Group
Enzo Biochem
Fujirebio
Grifols
Hologic/Gen-Probe
1D Biomedical/GSK
Kreatech/Leica
Lonza
Ortho-Clinical Diagnostics
Qiagen
Roche
Scienion
Sequenom
SeraCare
Siemens
Takara Bio
Thermo Fisher
Wallac
Wako

L1ST OF TABLES

Major Companies Developing or Marketing Chlamydia Tests
Major Companies Developing or Marketing Gonorrhea Tests
Major Companies Developing or Marketing Herpes Tests
Major Companies Developing or Marketing Pap Smear/HP5 Tests
Major Companies Developing or Marketing Syphilis Tests
France Chancroid Test 5olume and Diagnostics Sales Forecast by Market Segment
France Chlamydia Test 5olume and Diagnostics Sales Forecast by Market Segment
France Chlamydia Diagnostics Sales by Major Supplier
France Gonorrhea Test 5olume and Diagnostics Sales Forecast by Market Segment
France Gonorrhea Testing Market Diagnostics Sales by Major Supplier
France Herpes Simplex 1 and 2 Test 5olume and Diagnostics Sales Forecast by Market Segment
France Herpes Type 6 Test 5olume and Diagnostics Sales Forecast by Market Segment
France Herpes Testing Market Diagnostics Sales by Major Supplier
France PAP Smear Test 5olume and Diagnostics Sales Forecast by Market Segment
France Papillomavirus (HP5) Test 5olume and Diagnostics Sales Forecast by Market Segment
France Syphilis Test 5olume and Diagnostics Sales Forecast by Market Segment
France Syphilis Testing Market Diagnostics Sales by Major Supplier


More Publications